Skip To Main Content

Intended for US Payers

Inflammation and immunology

Inflammation and immunology R&D

Immunoscience is the backbone of our research

Our research investigates:

Illustration representing monoclonal antibodies.

Monoclonal antibodies

Illustration representing bispecific antibodies.

Bispecific antibodies

Illustration representing SYNTHROINᵀᴹ molecules.

SYNTHORIN™ molecules

Illustration representing protein degraders.

Protein degraders

Illustration representing NANOBODY® molecules.

NANOBODY^® molecules

Illustration representing small molecules.

Small molecules

Search for a specific clinical-stage project

FDA-approved products in inflammation and immunology

Our current portfolio includes approved treatments for:

Asthma

Product information

Atopic dermatitis

Product information

Chronic rhinosinusitis with nasal polyposis

Product information

Eosinophilic esophagitis

Product information

Polymyalgia rheumatica

Product information

Prurigo nodularis

Product information

Rheumatoid arthritis

Product information

Search for other FDA-approved products

Explore our other areas of focus

Illustration of the human brain to represent the therapeutic area of neurology.

Neurology

Illustration of a tumor to represent the therapeutic area of oncology.

Oncology

Illustration of a white blood cell, a red blood cell, and platelets to represent the therapeutic area of rare blood disorders.

Rare blood disorders

Illustration of DNA strand to represent the therapeutic area of rare diseases.

Rare diseases

Let’s connect

Schedule a meeting with a Sanofi Market Access team member to discuss how our therapies can bring value to your plan and members living with inflammatory or immune diseases.

This site is intended for US payers only.
© 2024 Sanofi. All rights reserved.